Rinderpest causes a devastating disease, often fatal, in wild and domestic ruminants. It has been eradicated successfully using a live, attenuated vaccine from most part of the world leaving a few foci of disease in parts of Africa, the Middle East, and South Asia. We have developed transgenic peanut (Arachis hypogaea L.) plants expressing hemagglutinin (H) protein of rinderpest virus (RPV), which is antigenically authentic. In this work, we have evaluated the immunogenicity of peanut-expressed H protein using mouse model, administered parenterally as well as orally. Intraperitoneal immunization of mice with the transgenic peanut extract elicited antibody response specific to H. These antibodies neutralized virus infectivity in vitro. Oral immunization of mice with transgenic peanut induced H-specific serum IgG and IgA antibodies. The systemic and oral immunogenicity of plant-derived H in absence of any adjuvant indicates the potential of edible vaccine for rinderpest.
Introduction
Rinderpest virus (RPV) is an important member of the genus Morbillivirus in the family Paramyxoviridae. RPV causes an acute, febrile, and highly contagious disease characterized by high fever, erosive stomatitis, gastroenteritis, dehydration, and death (Scott, 1964) . It affects primarily cattle and buffaloes; although all the members of the order Artiodactyla are susceptible to natural infection (Scott, 1959) , the infection spreads rapidly through close contact with infected animals. There is only one serotype of RPV, which is highly immunogenic. A live, attenuated tissue culture-adapted vaccine developed by Plowright (1962) is very effective and is one of the few tools available to control the spread of disease. However, because the vaccine is heat labile, it requires maintenance of cold chain to keep the potency of the vaccine. Several attempts have been made to develop a heat stable vaccine, using vaccinia, capripox, and baculoviruses as vectors (Bassiri et al., 1993; Romero et al., 1993 Romero et al., , 1994 Yilma et al., 1988) . The recombinant viral vectors were designed to express RPV surface glycoproteins namely hemagglutinin (H) and fusion (F) protein alone or in combination. The efficacy of these recombinants as a vaccine has been tested in experimental animals and shown to induce humoral and cell-mediated protective immune response. Recombinant vaccinia expressing H has been shown to provide long-term immunity in cattle (Ohishi et al., 2000; Verardi et al., 2002) and also recombinant capripox rinderpest virus vaccine has recently been tested for long-term immunity in African cattle (Ngichabe et al., 2002) . In spite of being robust, these subunit vaccines are not cost effective if they are required for mass vaccination purposes. Another point of consideration is that all these attempts are oriented toward parenteral delivery of the antigens. Because most of the pathogen colonize and invade the host at mucosal surfaces, the induction of immunity through vaccination at these sites is a logical and attractive approach to prevent infection. Parenteral antigen delivery does not induce significant mucosal immunity, which is better achieved by delivery of the antigen orally. Mucosal delivery could become a better tool for the management of diseases associated with mucosal surface.
Use of plants as an expression system not only provides an economical means of bulk production of foreign proteins but also oral uptake of edible parts of the transgenic plants expressing protective antigens that will induce the desired mucosal immune response. The concept of edible vaccine put forward by Arntzen (Mason et al., 1992) is followed by development of transgenic plants expressing a variety of antigens from disease-causing organisms especially of human interest (Haq et al., 1995; Huang et al., 2001; Mason et al., 1996; McGarvey et al., 1995; Sandhu et al., 2000; Thanavala et al., 1995) . Human trials have shown the induction of mucosal and systemic immune response to antigen delivered in the form of uncooked food (Tacket et al., 1998) . In order to produce an edible vaccine for rinderpest, it is necessary to look for the expression of the protective antigen in a model plant system and test the immunogenicity of the expressed protein. We have recently developed transgenic tobacco expressing hemagglutinin protein of RPV and shown that tobacco-derived H is able to induce good levels of specific immune response in mouse when inoculated intraperitoneally (Khandelwal et al., 2003a) . For oral delivery of a vaccine antigen, targeted crop should produce the antigen in edible tissues that can be eaten raw. Grains and legumes are the commonly used fodder for animal consumption. Peanut (Arachis hypogaea L.), an oil seed legume, is used as a fodder crop in many tropical and subtropical regions of the world. We communicate in the present study the antigenic authenticity of hemagglutinin protein of rinderpest virus expressed in transgenic peanut (A. hypogaea L.) plants and its oral immunogenicity. The immune response was evaluated in a mouse model. Induction of high levels of specific antibody response to peanut-derived H was observed upon intraperitoneal immunization. The protective ability of H-specific antibodies was demonstrated by neutralization of virus infectivity in vitro. Oral immunization of mice with transgenic peanut leaves expressing H elicited significant mucosal and systemic immune response. To our knowledge, this is the first report demonstrating induction of mucosal immune response to RPV antigen delivered orally. Thus, transgenic peanut plants expressing H could provide a novel way of mass immunization of cattle and susceptible wild life.
Results

Peanut-derived hemagglutinin protein is antigenically authentic
The authenticity of peanut-derived hemagglutinin protein was determined by its reactivity with different anti-bodies specific to H in ELISA ( Fig. 1) . Protein extracts were made from leaves of transgenic plants expressing H from both T 1 and T 2 generations and also from vectortransformed plant. The protein extract from transgenic plants reacted with serum from cattle immunized with baculo-recombinant H (Figs. 1B and C) and convalescent serum from cattle recovered after RPV infection (Figs. 1D -F). The peanut-derived H cross-reacted well with antibodies to hemagglutinin neuraminidase protein (HN) of antigenically related virus, peste des petits ruminants virus (PPRV) (Fig. 1G ), and also with convalescent serum from sheep infected with PPRV ( Fig. 1H ). The protein extract from vector-transformed peanut plant did not show reactivity to any of these antibodies. These results showed that Hexpressed in peanut plants is antigenically similar to virus-derived H protein.
Peanut-derived hemagglutinin induces specific antibody response upon intraperitoneal immunization
BALB/c mice received transgenic peanut extract or vector-transformed peanut extract through intraperitoneal immunization. Serum samples were tested in ELISA for the presence of specific antibodies using recombinant H as antigen. High levels of specific antibody to H were detected in the serum from mice immunized with transgenic peanut extract ( Fig. 2A) . The serum from all the five animals of each group (group 1: immunized with transgenic peanut extract, and group 2: vector-transformed peanut extract) was tested individually. The antibody response was monitored until 9 weeks post-immunization and the immunized animals maintained good levels of antibody. The specificity of these antibodies was confirmed by their reactivity to H protein made in infected cells by immunoblotting ( Fig. 2B) . A protein band at approximately 68 kDa was detected only in protein extracts from RPV-infected cells (lane 2), PPRVinfected cells (lane 3), and no signals were detected with uninfected Vero cell extract (lane 1) when pooled serum from peanut-H immunized animals was used as primary antibody. No detectable signals were obtained when serum from mice, which received vector-transformed peanut extract, was used as primary antibody (data not shown).
The specificity of the antibody produced following intraperitoneal immunization with peanut-derived H was further evaluated by hemagglutination inhibition assay. The hemagglutinin protein of antigenically closely related virus, peste des petits ruminants virus (PPRV), has been shown to possess hemagglutination activity (Ramachandran et al., 1995) . Therefore, the inhibition of hemagglutination activity of PPRV by pooled serum from all the five mice of group 1 collected at weekly intervals was tested and shown to possess hemagglutination inhibition activity (Fig. 3 ). This hemagglutination inhibition activity was not observed when pooled serum from all the five mice of group 2 was used in a similar assay, thus showing the specificity of antibody response.
Intraperitoneal immunization with peanut-derived H generates antibody, which neutralizes virus infectivity in vitro
The protective ability of specific antibody elicited following intraperitoneal immunization with extract from transgenic peanut expressing H was demonstrated by neutralization of virus infectivity in vitro. Table 1 shows the induction of high titers of neutralizing antibodies. These immune sera are not only able to neutralize RPV infectivity but also PPRV infectivity in vitro (data not shown). However, no neutralization or cross-neutralization activity was detected when pooled serum from mice of group 2 was tested in vitro.
Oral immunization with transgenic peanut leaves expressing H induces mucosal and systemic immune response
Mice were fed with either 1 g transgenic peanut leaves pooled from different lines expressing H (f0.5% of total soluble protein) or with 1 g nontransformed peanut leaves. The serum was collected every week and analyzed for the presence of H specific IgG ( Fig. 4A ) and IgA (Fig. 4B ). The peanut-derived H was able to induce significant levels of serum IgG in 1 week. The booster effect was not apparent until fourth week at which time the level of antibody had decreased compared to the first week. There was also an increase in IgA level that followed a similar trend. The reason for the initial surge in the antibody levels and a delayed booster effect is not clear. H-specific serum IgG or IgA level was maintained almost at the same levels, and the given dose did not result in oral tolerance. The animals, which received the antigen through oral route, showed the presence of secretory antibody in the intestinal extract even after 13 weeks post-immunization (data not shown). Mice that received nontransformed peanut leaves did not elicit any H-specific antibody response.
Oral delivery of peanut-derived H elicits lymphoproliferative responses
The splenocytes collected from mice at 13 weeks postoral immunization with transgenic peanut leaves showed in vitro proliferation in presence of specific antigen. Lymphocytes underwent proliferation in a dose-dependent manner suggesting the presence of primed cells (Fig. 5 ). Additionally, these lymphocytes did not proliferate in response to uninfected cell lysate. Further, the specificity of proliferation was tested by the ability of lymphocytes to proliferate in response to recombinant viral antigens such as H, N (nucleocapsid protein), and M (matrix protein). The lymphocytes from orally primed animals proliferated in response to recombinant H and not to N or M. The lymphocytes from mice that received nontrans- Table 1 In vitro neutralization of RPV infectivity by serum collected from mice after intraperitoneal immunization with transgenic leaf extract or with vectortransformed peanut leaf extract Fig. 3 . Hemagglutination inhibition assay. Hemagglutination inhibition titers of pooled serum from five mice after immunization (i.p.) with transgenic peanut leaf extract (group 1:x) and with vector-transformed peanut leaf extract (group 2: n) measured at every week after immunization for 9 weeks. Hemagglutination inhibition titer is defined as the reciprocal of the dilution, which showed 50% hemagglutination inhibition. formed peanut leaves orally did not respond to any of the antigen.
Discussion
The hemagglutinin protein present on the envelope of RPV is highly immunogenic and protective as shown earlier (Ohishi et al., 2000; Romero et al., 1994; Yilma et al., 1988) . Recombinant capripox virus (Romero et al., 1994) or vaccinia virus (Yamanouchi et al., 1993; Yilma et al., 1988) expressing H alone have been shown to confer protection against rinderpest. Although these subunit vaccines are able to overcome the major disadvantage of tissue culture-adapted vaccine (Plowright, 1962) , which is heat stability, they are prohibitively expensive for large-scale production and need expertise. Further, the debate on the safety aspects of use of vaccinia virus-based vaccine is still not resolved. Use of plants as source of vaccine proposed by Arntzen (Mason et al., 1992) has dual advantage. First, they provide an inexpensive way to produce the protective antigen in bulk, and second, if expressed in edible parts, the plant can be eaten raw offering a novel way of antigen administration. Earlier, we had generated transgenic tobacco plants expressing H protein as a model system to demonstrate that tobacco-derived H is antigenically authentic and immunogenic in a mouse model (Khandelwal et al., 2003a) . High levels of alkaloids present in tobacco make it unsuitable for animal feeding experiments. We have selected peanut as the plant of choice to express hemagglutinin protein because the plants are used as cattle feed after harvest in developing countries, and in the present communication, we have evaluated the antigenicity and oral immunogenicity of peanut derived-H.
H protein expressed in peanut is antigenically authentic as it was recognized by specific antibodies including convalescent serum from animals recovered from either RPV or PPRV infection. The immune responses elicited by the peanut-derived H are comparable to what is obtained by recombinant viral vectors. It has been shown for measles virus that the mode of antigen presentation determines the extent of immune response (Wild et al., 1992) and our results are in accordance with this. A small amount of H (10 Ag) present in the total soluble protein results in high titers of specific antibody response when given intraperitoneally (Fig. 2) suggesting that the presence of other plant proteins are helping the presentation of peanut-derived H to the components of the immune system. The specificity of the induced antibody response is evident by the fact that mice immunized with the extract from vector-transformed plant do not show any detectable immune response at the given dose. Similarly, mice fed orally with transgenic peanut leaves elicited significant immune responses (Fig. 4) . Earlier, it has been reported that recombinant H protein of RPV elicits both humoral and cell-mediated responses in cattle (Sinnathamby et al., 2001) . In the present work, oral feeding of mice with transgenic peanut leaves expressing H without any mucosal adjuvant not only induces humoral responses as determined by serum IgG and IgA specific to H but also primes T cells, the major component of cell-mediated immune response. This suggests that some plant component, mainly lectins, might be responsible for induction of systemic and mucosal immune response by facilitating the entry of peanut-derived antigen across the mucosal barrier. Additionally, it has been previously suggested that the expression of antigens in plants will provide a ''bio-encapsulation'' to the antigens thus resulting in elicitation of significant mucosal immune response to antigen that is otherwise difficult to achieve (Kong et al., 2001) . Because the use of adjuvant will stimulate the mucosal immune system nonspecifically resulting in induction of immune response to the normal diet of an individual, the results obtained without any oral adjuvant assume greater significance. Another important feature of the results from the present work is that the formulation used for oral immunization does not cause oral tolerance, instead elicited good immune responses.
The reports available on developing edible vaccine for human and animal diseases deal with expression of the candidate antigen in the target plant species and immune responses in murine models. LT-B of E. coli (Tacket et al., 1998) and capsid protein of Norwalk virus (Tacket et al., 2000) when expressed in potato elicit high levels of immune response in humans. Eating raw potato causes stomach discomfort or nausea due to presence of alkaloids in potato as experienced by few of the volunteers receiving transgenic potatoes expressing LT-B (Tacket et al., 1998) . Among the viral disease of livestock, efforts have been made in developing edible vaccine for foot and mouth disease (Carrillo et al., , 2001 Dus Santos et al., 2002; Wigdorovitz et al., 1999a Wigdorovitz et al., , 1999b and transmissible gastro- enteritis (Gomez et al., , 2000 Tuboly et al., 2000) . However, in case of animal diseases, there are no reports describing induction of mucosal and systemic immune responses upon oral delivery through food in the host animal, although these responses have been obtained in mouse system. VP1 protein of foot and mouth disease virus when expressed in arabidopsis and potato (Carrillo et al., , 2001 and in tobacco (Wigdorovitz et al., 1999b ) is shown to induce protective immune response in mice upon intraperitoneal immunization. Wigdorovitz et al. (1999a) have also shown that oral or parenteral immunization of mice with alfalfa expressing VP1 induces protective immune response. The expression levels were found to be in the range of 0.005 -0.01% of the total soluble protein as estimated by ELISA and even the promoter modification did not result in significant increase of the VP1 expression in transgenic lines (Carrillo et al., 2001) . We have selected peanut as the target plant, which is also a fodder crop, and the peanut-expressed hemagglutinin protein induces high levels of specific antibody response upon intraperitoneal immunization with extract from transgenic peanut leaves or oral immunization with peanut leaves. Protection provided at the entry site of the infectious organism would not only protect the animal from the disease but also prevent the infection altogether. Oral immunogenicity of peanutexpressed H protein in the target animal cattle has been recently shown (Khandelwal et al., 2003c) ; however, it was necessary to find if the peanut-derived protein is able to elicit secretory IgA response after oral feeding. In conclusion, a safe, easy to administer and cost effective, both in terms of production and storage, candidate vaccine has been produced in transgenic peanut plants and the plantexpressed H is immunogenic when given orally without adjuvant in a model animal. This may provide a novel way of protecting livestock against rinderpest disease.
Materials and methods
Animals BALB/c (H-2 d ) female mice 60 -90 days old were procured and maintained at Central Animal Facility, Indian Institute of Science, Bangalore, India.
Cells and virus
Vero cells were obtained from National center for cell Science, Pune, India, and were maintained in MEM supplemented with 5% fetal calf serum (Gibco-BRL, USA). A tissue culture-adapted vaccine strain of RPV (RBOK) (Plowright and Ferris, 1957) was obtained from the Institute of Animal Health and Veterinary Biologicals, Bangalore, India, and vaccine strain of peste des petits ruminants virus (PPRV) Nig 75/1 was provided by Dr. A. Diallo, CIRAD-EMVT, France.
Recombinant proteins
Recombinant hemagglutinin (H) protein expressed in insect cells secreted into the medium was used . Recombinant nucleocapsid of RPV expressed in E. coli was purified on Ni affinity column as described earlier (Mitra-Kaushik et al., 2001) . The full-length M gene of RPV (RBOK) was cloned into pBluesript KS + vector (kindly provided by Dr. M. Baron, Institute for Animal Health, Pirbright, UK), was subcloned into pRSET expression vector, and expressed in E. coli BL21 (DE3) (Shaji and Shaila, unpublished) .
Antibodies
H-specific antibodies made in cattle in response to immunization with a baculo-recombinant virus expressing H protein are described earlier (Sinnathamby et al., 2001) . Convalescent sera from cattle recovered from RPV infection or sheep recovered from PPRV infection were collected during field outbreaks. Generation of mouse monoclonal antibody to baculo-recombinant secretory H is described in Renukaradhya et al. (2002) . Polyclonal monospecific antibodies to RPV H purified from infected cell extracts were generated in rabbits (Devirddy et al., 1998) .
Transgenic peanut plants
The hemagglutinin gene (H) of attenuated strain (RBOK) of rinderpest virus was subcloned into binary vector pBI 121. In the recombinant binary vector pBI H, the H gene is under the control of constitutively expressed CaMV 35S promoter. pBI H was mobilized into Agrobacterium tumefaciens (EHA 105). Transgenic peanut plants obtained using pBI121 served as the control and termed as vector-transformed peanut plants. Transgenic peanut plants expressing hemagglutinin protein were generated via Agrobacterium-mediated transformation of shoot apices (Khandelwal et al., 2003b) .
ELISA
Total protein from leaves of transformed and nontransformed peanut plants was isolated using the method of McGarvey et al. (1995) . Twofold serial dilution of plant extracts was performed in phosphate buffer, pH 7.4 (PBS), and coated onto ELISA plates at 4 jC overnight. All further incubations were at 37 jC for 1 h and the plate was washed thrice with PBS containing 0.15 Tween 20 (PBST). Blocking was done in 0.2% fish gelatin in PBST (v/v). Appropriate antibody dilutions were made for all primary antibodies followed by peroxidase-conjugated anti-cow, anti-sheep (purchased from Dacopatts, Denmark), or antirabbit (purchased from Boehinger and Mannheim) antibodies as secondary antibodies. The HRP antibody was developed with o-phenylenediamine (OPD) for 10-15 min and read at 490 nm.
Immunizations
Two groups, each containing 5 BALB/c mice, were immunized intraperitoneally with leaf extracts from transformed peanut plants expressing highest level of H and vector-transformed peanut plants (10 Ag of H per mouse) in complete Freund's adjuvant for the first injection followed by two boosters with half of the protein amount on 7 and 14 days in incomplete Freund's adjuvant. Mice were bled retroorbitally every week until 10 weeks post-immunization and serum was collected and tested for the presence of specific antibodies to H by ELISA using recombinant H as the antigen. Antibody titers are expressed as the log of reciprocal of the highest serum dilution that gives OD readings twice the mean OD of serum from five mice immunized with vector-transformed peanut plant extract.
For oral immunization, two groups of mice each containing four animals were used. Animals were starved overnight before feeding in the morning. They were fed with 1 g of peanut leaves (either transgenic leaves, group 1 or nontransformed peanut leaves, group 2) corresponding to 10 Ag of H per feeding once a week for five consecutive weeks.
Hemagglutination inhibition assay
Hemagglutination inhibition test to detect specific antiserum was done employing PPRV, closely related to RPV, which has been shown to possess hemagglutination activity (Ramachandran et al., 1995) using the method previously described by Norrby (1962) .
Virus neutralization test
Serum samples collected at various time points were tested for the presence of neutralizing antibodies (both homologous and cross-neutralizing) in triplicates using flatbottomed 96-well plates as described by Barrett et al. (1989) . Vaccine strain of RPV (RBOK strain) and vaccine strain of PPRV Nig 75/1 were grown on Vero cells and titrated employing TCID 50 method (Reed and Muench, 1938) . Pooled serum samples (for each bleed, serum was pooled from all the five mice of the group) were heat inactivated at 56 jC for 30 min and then serially diluted twofold with culture medium, starting from an initial dilution of 1:20. Following incubation with 100 TCID 50 of virus at 37 jC for 1 h, 2 Â 10 4 cells were added to each well. The wells without the sera or virus served as control. The plates were monitored for 5-7 days for cytopathic effects (CPE) for RPV and 3 -5 days for PPRV. Virus neutralization titer was defined as the highest dilution of the sera, which inhibited CPE by 50%.
In vitro lymphoproliferation
Spleen was collected from orally immunized animals at 13 weeks. Lymphoid cell suspension was subjected to ficoll-Hypaque (Pharmacia) density centrifugation at 3000 rpm for 30 min. The buffy coat was collected and diluted in excess PBS. The cells were recovered by centrifugation, washed, and resuspended in RPMI 1640 supplemented with 10% FBS (Gibco BRL). The lymphocytes were proliferated in triplicates at a density of 2 Â 10 4 cells per well in presence of varying amounts of RPV-infected cell lysate or uninfected cell lysate or recombinant proteins in a final volume of 200 Al per well for 5 days. The cells were pulsed with 1 ACi [ 3 H]-thymidine (specific activity 6500 mCi/mmol; Amersham) for 16 h and harvested on glass fiber filters. The incorporated radioactivity was measured in a Rackbeta scintillation spectrometer.
